Big pharma racing to hedge patent expiry
Por Reuters — Reuters
Pharma firms closed biopharma buyouts worth over a hundred billion dollars in the first half of the year, racing to replace top selling medicines worth around $400 billion before patents expire. Leah Bennett of Concurrent explains.
#News #Reuters #Newsfeed #PharmaIndustry #Biotech #Concurrent #PatentCliff #PharmaMergers #DrugPatents #BiopharmaDeals #BusinessNews #InvestingNews #HealthcareIndustry #MergersAndAcquisitions #2033PatentCliff #PharmaStocks #BiotechInvesting #DrugDevelopment #WallStreet #MarketNews #PharmaDeals #Reuters
👉 Subscribe: https://reut.rs/4b8fRGn
Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on X: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Fonte: Reuters
